What is the NPR longevity drug?: Decoding the Science of Rapamycin and Other Promising Candidates
•
3 min read
In July 2024, NPR reported on a clinical trial testing rapamycin, a generic drug known to extend lifespan in animals, for its potential anti-aging effects in humans. The 'NPR longevity drug' primarily refers to **rapamycin**, though NPR has covered other compounds, such as metformin and senolytics, underscoring the growing field of pharmacological interventions aimed at delaying age-related decline.
